Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
Supernus Pharmaceuticals, Inc. (SUPN) had Current Liabilities of $290.20M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$607.52M |
|
$1.32M |
|
$83.78M |
|
$523.74M |
|
$612.79M |
|
$-5.27M |
|
$8.04M |
|
$2.77M |
|
$2.77M |
|
$1.32M |
|
$1.32M |
|
$1.32M |
|
$1.32M |
|
$-5.27M |
|
$80.00M |
|
54.54M |
|
55.51M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$493.11M |
|
$13.53M |
|
$784.56M |
|
$1.28B |
|
|
Current Liabilities |
$290.20M |
-- |
|
$65.96M |
|
$356.16M |
|
$921.52M |
|
$204.61M |
|
$921.52M |
|
54.72M |
|
| Cash Flow Statement Financials | |
$111.08M |
|
$268.73M |
|
$-397.88M |
|
$93.12M |
|
$75.05M |
|
$-18.07M |
|
$26.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.21% |
|
-0.87% |
|
-0.87% |
|
13.17% |
|
0.46% |
|
0.22% |
|
$110.53M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
1.08 |
|
4.21 |
|
86.61 |
|
0.14% |
|
0.64% |
|
0.10% |
|
0.14% |
|
$16.84 |
|
$1.99 |
|
$2.00 |
|